seizure - Nursing Case Study

Pathophysiology

• Primary mechanism: Seizures occur due to abnormal electrical discharges in the brain, often stemming from an imbalance between excitatory neurotransmitters like glutamate and inhibitory neurotransmitters like GABA. This imbalance disrupts normal neuronal firing.

• Secondary mechanism: Alterations in ion channels, particularly sodium, calcium, and potassium channels, can contribute to increased neuronal excitability. This results in a lowered threshold for depolarization, facilitating the spread of abnormal electrical activity across the brain.

• Key complication: Prolonged or recurrent seizures can lead to neuronal injury, cognitive impairment, and increased risk of developing epilepsy, stressing the importance of timely intervention and management.

Patient Profile

Demographics:

28-year-old female, software engineer

History:

• Key past medical history: Epilepsy diagnosed at age 20, occasional migraines

• Current medications: Lamotrigine 100 mg twice daily, Ibuprofen as needed for migraines

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased frequency of seizures over the past two weeks

• Key symptoms: Aura of dizziness and confusion before seizures, recent episodes of prolonged seizures lasting up to 3 minutes, postictal fatigue, and mild headache

• Vital signs: Blood pressure 148/92 mmHg, heart rate 102 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 94% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, the medical team ordered several diagnostic tests to further evaluate the increased frequency and severity of the patient's seizures. An electroencephalogram (EEG) was conducted, revealing increased epileptiform activity, particularly in the left temporal lobe. This finding suggests a focal onset of the seizures, which may be contributing to the patient's recent changes in seizure pattern. Additionally, a routine blood panel was performed, showing a slightly elevated white blood cell count at 11,500/mm³, indicating potential infection or inflammation, although no fever was present. Serum electrolytes were within normal limits, ruling out an acute metabolic cause for the increased seizure activity.

A magnetic resonance imaging (MRI) of the brain was also performed to rule out any structural abnormalities. The MRI findings revealed subtle hippocampal sclerosis on the left side, which could be related to the patient's history of epilepsy and may be exacerbating her current condition. Given these findings, the clinical team is considering adjusting her antiepileptic medication regimen and initiating further investigation into potential triggers, such as stress or sleep deprivation, that might be contributing to the recent increase in seizure activity. This comprehensive evaluation provides a clearer picture of the underlying neurological changes and guides the next steps in her management plan, emphasizing the need for a balanced approach in treating both the seizures and any underlying contributing factors.

Section 2

Change in Patient Status:

Two days following the adjustment of her antiepileptic medication regimen, the patient experienced a notable change in her clinical status. She was brought to the emergency department after having multiple seizures within a 24-hour period, classified as a cluster of complex partial seizures with secondary generalization. Upon arrival, the patient was confused and lethargic, with a Glasgow Coma Scale (GCS) score of 13, indicating mild impairment in consciousness. Her vital signs were stable, with a blood pressure of 120/80 mmHg, heart rate of 92 beats per minute, respiratory rate of 18 breaths per minute, and oxygen saturation at 96% on room air. However, the patient was observed to have mild cyanosis around the lips, suggesting a potential compromise in respiratory function during her seizures.

A repeat blood panel showed further elevation of the white blood cell count to 13,000/mm³, along with a slight increase in C-reactive protein (CRP), indicating ongoing inflammation or infection. Despite these findings, the patient remained afebrile. Notably, the patient reported experiencing significant stress related to work and family obligations, which she believed had worsened her sleep quality over the past few weeks. This information prompted the healthcare team to consider stress and sleep deprivation as exacerbating factors for her seizures. The team also noted a slight decline in renal function, with the patient's creatinine levels rising from 0.9 mg/dL to 1.3 mg/dL, necessitating careful monitoring, particularly in the context of adjusting her medication regimen.

In response to these developments, the clinical team initiated a more aggressive management plan focusing on seizure control and addressing potential triggers. This included the introduction of an additional antiepileptic drug and temporary corticosteroid therapy to manage potential inflammation. Furthermore, the patient was provided with resources for stress management and sleep hygiene, emphasizing the importance of holistic care in managing epilepsy. The team also decided to conduct a lumbar puncture to rule out any central nervous system infections, given the elevated inflammatory markers. These steps aim to stabilize the patient's condition and prevent further complications, setting the stage for ongoing evaluation and adjustment of her treatment plan.

Section 3

New Diagnostic Results:

Following the initial assessment and intervention, the healthcare team proceeded with the lumbar puncture to rule out any central nervous system infections as a potential cause of the patient's elevated inflammatory markers. The cerebrospinal fluid (CSF) analysis returned clear, with no presence of bacteria, suggesting that a central nervous system infection was unlikely. However, the CSF did show a mildly elevated protein level, which can sometimes be seen in patients with ongoing seizures or other neurological conditions. This finding, while not immediately alarming, prompted further investigation to rule out any underlying chronic neurological disorders that could have been exacerbated by recent medication changes and stress factors.

Simultaneously, an EEG was conducted to assess the electrical activity in the patient's brain. The results demonstrated intermittent epileptiform discharges, which are indicative of a heightened seizure propensity, consistent with her recent seizure cluster. These findings confirmed the necessity of the new antiepileptic drug regimen, as the current treatment strategy was insufficient in suppressing seizure activity. Additionally, an MRI of the brain was ordered to evaluate any structural abnormalities that might contribute to the patient's condition. The MRI results were largely unremarkable except for some mild hippocampal sclerosis, which could be contributing to her complex partial seizures.

The diagnostic results provided the clinical team with critical insights into the patient's condition. With a clearer understanding of the underlying factors contributing to her seizures, the team emphasized the need for a comprehensive approach that not only addresses seizure control pharmacologically but also manages the patient's stress and sleep hygiene. The mildly elevated CSF protein and EEG findings underscored the importance of vigilant monitoring as the patient navigates both medication adjustments and lifestyle modifications. The patient was counseled on these findings, reassured about the plan, and encouraged to engage actively in her care to optimize outcomes.

Section 4

Following the adjustments to the patient's antiepileptic regimen and lifestyle recommendations, the healthcare team closely monitored her clinical status for any changes. Initially, the patient responded well; her seizure frequency decreased, and she reported improved sleep patterns due to better adherence to sleep hygiene practices. However, within a week, she returned to the emergency department after experiencing a prolonged complex partial seizure that evolved into status epilepticus. This episode lasted over 30 minutes and required intravenous benzodiazepines to terminate.

Upon reassessment, her vital signs were stable: blood pressure 128/82 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, and oxygen saturation at 96% on room air. However, she appeared fatigued and slightly disoriented, which was attributed to postictal confusion. Laboratory results indicated a slight metabolic acidosis with a bicarbonate level of 19 mEq/L, likely due to the prolonged seizure activity. Her serum sodium level was mildly low at 133 mEq/L, raising concerns about potential water retention or SIADH as a complication of antiepileptic drug usage or stress from the seizure.

The clinical team recognized that the emergence of status epilepticus represented a significant complication in her management plan. The decision was made to admit her for closer monitoring and to reassess her medication regimen, considering the need for potentially adding a second-line agent to prevent further episodes. This adjustment would require careful titration and monitoring of side effects, as well as continued emphasis on non-pharmacological strategies to mitigate stress and improve overall neurological stability.

Section 5

As the patient settled into the inpatient unit, the clinical team conducted an initial assessment to gather more comprehensive data. Neurological evaluation revealed that she remained in a postictal state longer than anticipated, with persistent confusion and decreased responsiveness, which necessitated close neurological checks. Her Glasgow Coma Scale (GCS) fluctuated around 13, indicating mild impairment in consciousness. Despite stable vital signs, the extended duration of her postictal phase suggested a need for further investigation into underlying causes, such as subclinical seizures or medication side effects.

Concurrently, additional laboratory tests were ordered to elucidate the cause of her mild hyponatremia. The results indicated an increase in urine osmolality at 650 mOsm/kg and a low serum osmolality of 275 mOsm/kg, strengthening the suspicion of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) potentially induced by the antiepileptic medication or stress response. The team decided to restrict her fluid intake and closely monitor her sodium levels, while considering adjustments to her medication regimen to address this complication.

In response to these findings, the clinical team began adjusting her treatment plan. Levetiracetam, the initial antiepileptic, was tapered while introducing a low-dose of lamotrigine, known for its stabilizing effects and lower risk of inducing SIADH. The decision required careful titration to minimize adverse effects and ensure effective seizure control. Meanwhile, emphasis on non-pharmacological interventions, such as stress management techniques and enhanced sleep hygiene, was reinforced to support her neurological recovery and prevent future complications. These strategic adjustments were crucial to stabilizing her condition and guiding her towards a more sustainable recovery trajectory.